Management of hypercholesterolemia: evaluation of practical clinical approaches in healthy young adults.
A work site-located clinic screened 6,000 employees (91 percent participation) and identified 146 hypercholesterolemic subjects (100 percent initial participation, 12 percent subsequent dropout rate). The subjects, aged 20 to 50 years, were randomly classified into four groups: Group A, treatment in a lipid intervention clinic with diet for 6 weeks, then diet plus clofibrate for the subsequent 18 weeks; Group B, diet treatment from a clinic nutritionist with the cooperation of the subject's private physician; Group C, referral for treatment by a private physician; and Group D, no intervention. Initial mean cholesterol was 294 mg/100 ml. At 24 weeks, all intervention groups had decreases in serum cholesterol (Group A, 12 percent; Group B, 15 percent; Group C, 17 percent; P less than 0.001). The control group (D) had a small decrease in cholesterol (4 percent). Decreases in cholesterol were correlated with weight loss and decrease in fasting serum triglycerides but not with the use of clofibrate. Serum cholesterol can be reduced in healthy young adults by several practical methods.
D000328:Adult; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use*; D004041:Dietary Fats; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D062085:RNA, Long Noncoding; D022661:RNA, Untranslated / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
D004041:Dietary Fats; C405430:ENOD40 RNA; D008077:Lipoproteins, LDL; D062085:RNA, Long Noncoding; D022661:RNA, Untranslated; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate